Follicular lymphoma trials in United Kingdom

In United Kingdom 15 Also abroad 188

15 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Where
Manchester, Plymouth
Age
18 years and over
People
280 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07519772 · EU 2025-523005-15-00
Phase 1Taking people
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Where
Leeds, Oxford
Age
18 years and over
People
215 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07101328 · EU 2025-524180-20-00
Phase 1Taking people
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Where
London, Nottingham, Plymouth, Southampton
Age
18 years and over
People
460 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07226843 · EU 2025-523601-16-00
Phase 3Taking people
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Where
London, Newcastle upon Tyne, Norwich, Nottingham, Plymouth, Southampton
Age
18 years to 130 years
People
1,018 worldwide
Run by
AstraZeneca
See details and how to joinNCT06549595 · EU 2023-510098-33-01
Phase 2Taking people
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Where
London, Manchester, Norwich, Nottingham, Plymouth
Age
18 years and over
People
270 worldwide
Run by
AstraZeneca
See details and how to joinNCT06526793 · EU 2023-505789-27-00
Phase 3Taking people
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
Where
Bournemouth, Great Yarmouth, Plymouth, Romford, Salisbury, Sutton, Truro, Uxbridge, Warwick
Age
18 years and over
People
580 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06149286 · EU 2022-503092-28-00
Phase 3Taking people
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
Where
Bournemouth, Glasgow, Norwich, Plymouth, Romford, Truro
Age
18 years and over
People
822 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06091254 · EU 2022-502660-20-00
Phase 1/2Taking people
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Where
Edinburgh, Leeds, Newcastle upon Tyne, Newmarket, Norwich, Nottingham, Plymouth
Age
18 years and over
People
689 worldwide
Run by
BeOne Medicines
See details and how to joinNCT05006716 · EU 2022-502157-33-00
Phase 1Taking people
Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
Where
Leeds, Plymouth
Age
18 years and over
People
85 worldwide
Run by
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
See details and how to joinNCT06980116 · EU 2024-516869-36-00
Phase 1Taking people
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Where
Glasgow, Leeds, Liverpool, London, Manchester, Oxford, Plymouth, Southampton, Sutton
Age
18 years and over
People
572 worldwide
Run by
Nurix Therapeutics, Inc.
See details and how to joinNCT05131022 · EU 2023-510541-25-00
Phase 3Taking people
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
Where
Canterbury, Cringleford, London, Manchester
Age
18 years and over
People
400 worldwide
Run by
Celgene
See details and how to joinNCT06911502 · EU 2024-519152-82-00
Phase 2Taking people
Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy
Where
Aberdeen, Belfast, Birmingham, Blackpool, Cambridge, Cardiff, Coventry, Croydon, Glasgow, Leeds, Liverpool, London, Manchester, Newcastle, Norwich, Nottingham, Oxford, Sheffield, Southampton, Stoke-on-Trent, Swansea, Torquay
Age
18 years and over
People
284
Run by
University of Birmingham
See details and how to joinNCT05848765
No phaseTaking people
Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma
Where
Airdrie, Cheltenham, Manchester, Milton Keynes, Newcastle upon Tyne, Nottingham, Portsmouth, Truro
Age
18 years and over
People
700 worldwide
Run by
AbbVie
See details and how to joinNCT06830759
Phase 1/2Taking people
A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies
Where
Birmingham, Cambridge, Leeds, London, Manchester, Sutton
Age
16 years and over
People
84
Run by
Cancer Research UK
See details and how to joinNCT06045910
No phaseNot yet taking people in United Kingdom
The Microbiome in Blood Cancer and HLH
Where
Nottingham
Age
16 years to 100 years
People
750
Run by
University of Nottingham
See details and how to joinNCT06734624